Spironolactone use and oocyte maturation in patients undergoing controlled ovarian hyperstimulation.

Atoosa GhofranianSamantha L EstevezBethany DuboisCaroline GellmanDmitry GounkoJoseph A LeeAlan B CoppermanKimberly Thornton

Published in: Journal of assisted reproduction and genetics (2024)

This is the first study to evaluate the association between spironolactone and oocyte yield and maturation rates during COH cycles. These findings can assist in counseling patients on the implications of continuing spironolactone during COH cycle.

Keyphrases

patients undergoing
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
smoking cessation
hiv testing